CD8+ T-cell tolerance and immunity Boer, A.T. den

CD8+ T-cell tolerance and immunity

Boer, A.T. den

Citation

Boer, A. T. den. (2005, April 14). CD8+ T-cell tolerance and immunity. Retrieved from

https://hdl.handle.net/1887/2705

Version:

Corrected Publisher’s Version

License:

Licence agreement concerning inclusion of doctoral thesis in the

_{Institutional Repository of the University of Leiden}

Downloaded from:

https://hdl.handle.net/1887/2705

 &'7&(//668335(66$17,78025&7/5(63216(6

#$

SPECIFIC

!NNEMIEKE-IERLO*- -ELIEF

4OES $EPARTMENTS 2HEUMATOLOGY .ETHERLANDS !"342!#4 -ODULATIONESTABLISHED TUMORS MAY THERAPEUTIC COMPARED ANALYZED THE TOTUMOR SPECIFIC #$ 4 CRUCIALLY 6ACCINE IMMUNITY IN

DEPENDENT CELL SUBSET

PREVENTED₄

OF_{RING TUMORS}

EMPOWERED THE MICE 

IMMUNITY NEED 3PONTANEOUS ERADICATIONNITIALLY SIMILARLY OBSERVED SUPPORTING HARBOR A CLASS CAPABLE

IMMUNE RESPONSE 4HE

PRESENCE BE 4OGETHER SUPPRESSIVE TUMOR DEVELOPMENT BEPROFESSIONAL ANTIGEN PRESENTING THE TREATMENT ).42/$5#4)/. )N FREE

IMMUNITY NATION TUMOR BEARING

RECIPIENTSREASONS THE THE GROWING AIM IS TO &URTHERMORE MAJOR CHALLENGE ESTABLISHED 4UMOR SPECIFIC₄ TUMOR USUALLY

CELLSABOUTBETWEEN

#$ PROVIDED_LSALHE EFFECTIVE EVIDENCE TUMOR_{4 CELLS} ENHANCE INCREASED RECRUITMENT

 OGENESIS ASTIC CELL

PROLIFERATION IMMUNE AND THE ENHANCED_#$4 BEEN ALSO BEEN SHOWN TO PLAY

RESPONSES LS

RESPONSESHE TUMOR CELLS BUT COULD

POTENTIALLYAGAINST

BYOROR ANTIGEN4

CELLSFROM TUMOR INFILTRATING

MELANOMA PATIENT  

INDICATE

DIVERSEUMORS

4O

THE DEVELOPMENT OF TUMOR SPECIFICMUNITY

BEARING NATURALLY WEUMOR TUMOR $ IMMUNITY DERIVED )N INDUCTION ON OF _CELLS NUMBER ERADICATION

 &+$37(5 THAT FROM INHIBITS 4HESE IMMUNOTHERAPEUTICHE -!4%2)!,3 #ELL )-$- FE 4ECHNOLOGIES 'AITHERSBURG $ SUPPLEMENTED PENICILLIN !NIMALS #",B )&&!+H ( B ))  B .ETHERLANDS  4UMOR #", %*RAS _

CELLSICE 4UMOR VOLUMES

WEREWHEN

THEIR TUMORSARGERM_

)N#$ CELLS ANTI #$ '+  ANTIBODIES AND  ANTI #$ CELL TYPES WAS STARTED INJECTION 4REATMENT OF4HE WHICH IS ER 44#!4'!#'44##4'!#'44  0HARMACEUTICAL SUGGESTED OF  ±GINJECTION MORJECTION

&LOW!NALYSIS 4UMORSOVED

SMALL PIECES AND TREATED FOR  BY

SPLEEN MECHANICAL

DISRUPTION "LOOD SAMPLES

AMMONIUM IN

TEMPERATURE ED DIRECTLY

ALLOPHYCOCYANIN AGAINST #$ 0HAR-INGEN

CONJUGATED  LOADEDB

ACQUISITIONECTON $ICKINSON

&!#3CAN

2%35,43

2OLE

-ICE !D%! TRANSFORMED

PROTEIN

EPITOPES $ESPITEHIS

!D%! TRANSFORMED PROGRESSIVELY

GROWING

THESE

CELLSEOUSLYHAT THE %! PEPTIDE

RECOGNIZED DRAINING LYMPH ARE TUMOR BEARING MICE PROGRESSIVELY INCAPABLE MECHANISTIC RESPONSE

CELLSEACH SPECIFICICE

ESTABLISHED TUMORS THREE

!SDEPLETION OF #$ VACCINATION ABROGATES  U RV IV AL $AYS                     

!

"

!

"

&IG_TUMOR_{!D%RAS CELLS}

FLANK!„TEDSEDORS WITH

z

ESTABLISHED{

SHOWN !

 &'7&(//668335(66$17,78025&7/5(63216(6 IMMUNITY THE RESPONSES #$ TUMOR CAPACITY OF THE CELLS OUTGROWTH OF CELLS IN THESE #$

ERADICATION AND PROLONGED RECEIVED 4UMOR REJECTION

SPECIFICTHAT

4 MICE UNLEASHED POTENT ANTI TUMOR

IMMUNITY #$ #$₄ CRUCIALLY INVOLVED IN TUMORS   WE DETERMINED CELLS AFFECTED REMARKABLENUMBER CELLS IN &IG INOR BEARINGIN TUMOR

DRAINING LYMPH NODES IN RESPONSE EMERGING AFTER DETECTED IN 4HESE INITIALEXPANSION OF CELLS IN COMBINED_CELL #$PLETELY THAT REQUIRES  B %  !  CE LLS UNTREATED #$      B %  !  CE LLS UNTREATED #$    

&IG  #$ DEPLETIONEASED

4 CELLS

THE FLANK SC AND AT LEAST

ESTABLISHED_CELLS WERE DEPLETION $B _%!  IN PERIPHERAL BLOOD #OMBINED -ANN #$ ALSO THESE CELL TYPES OBSERVED EFFECTS OF #$

THE

MICE4

CONTAIN

WITHMORSITIALLY

BUT

TUMOR_DUCED

INJECTED WITH TUMOR NO

RESULTS

SUPPRESS_{4 CELL}

TUMOR BEARING ICE ORE THE COMBINED

OBSERVATIONS

OUTGROWTH OF AN

POPULATION

#$_MUNITY

REQUIRED IMMUNITY IN THE

PROPHYLACTIC TUMOR BEARING 3P LEEN $ RAI NI NG . . O N DR AI NI NG . 4U M O R #$ #ONTROL !B TREATED         #$ !0# $ B% ! 0 % 3P LEEN $ RAI NI NG . . O N DR AI NI NG . 4U M O R #$ #ONTROL !B TREATED         #$ !0# $ B% ! 0 %

&IG  #$ DEPLETIONEASED

4 CELLS

THE FLANK SC AND INJECTED ESTABLISHED TUMORS

.INETEEN DAYS AFTER THE START₄

CELLS B _%!

  TETRAMERS DETERMINED .UMBERS

POSITIVEPLOTS

 &+$37(5           $AYS  U RV IV AL           $AYS  U RV IV AL

&IG_{CELLSICE #", MICE WERE}

INJECTED UNTREATED„ ESTABLISHED… ANTIBODYz 5NTREATED 0 #$_#$

3UPPRESSION 4O UDY HER hCONVENTIONALv

#$_{#$REGULATORY CELLSNVOLVED}

TUMOR SPECIFIC DEPLETED #$ ANTI TUMOR 4HEREFORE CHALLENGE_#$   NOT _CELL

INFLUENCE TUMOR GROWTH DATA

WHETHER #$

POPULATION_CELLS

THREE DEPLETION

3INCEL ACTIVATED 4 CELLS DEPLETION

OF_{CELLS MAYBER}

CELLS

#$

SPECIFIC

INDICATING THATAIN

ARE RESULTS_#$CELLS INVOLVED IN MEDIATEDN !0# !CTIVATION  3UPPRESSION 3INCE PHASE _{MUNITY WE}

HYPOTHESIZED TIC SCHEMES

SUPPORTING THE THIS BY #$ IMPORTANT ANDNVESTIGATED !0# SUPPRESSION ANTI #$ ANTIBODIES DEMONSTRATED BY AN INCREASED EXPRESSINGDATA NOT CELL RESPONSE

#$AWHICH WAS CAPABLE

OF OF4HUS TREATMENT PROPER !0# CELLS $AYS            U RVI V AL   O R EARI N G MI C E           ! " $AYS            U RVI V AL   O R EARI N G MI C E           ! "

&IGEDICEz { MICE

IN

DEPLETIONTUMOR_LANK„

INJECTEDEz

… DEPLETED

 &'7&(//668335(66$17,78025&7/5(63216(6 $)3#533)/. )N THIS BEARING DEPLETION

RESULTS IN THE RAPID

SPECIFIC_TUMOR SPECIFIC CELLS APPEAR BECAUSE BY DEPENDENT INDICATE WEEKS 4 CELLS FOR _{4 CELL} DEVELOPMENT RESPONSES OVERCOME VIA INJECTION OF

INDICATING THAT THE

CELLS CAN BE BY PASSED

RESPECTIVELYOST

4HERAPEUTICCANCER TREATMENT

MORE DIFFICULT REASONS FOR

ARETHE INEFFECTIVENESS OF

ANTI TUMOR ASPECTS RELATES TO RAPIDLY CELLS PLAY IMMUNE FUNCTIONS MATURATION ARE IMPORTANT IN RESPONSES OF SPECIFIC_{4 CELLO} SECONDARY ENCOUNTER OF ANTIGEN   )T CENTRAL₄ EFFECTOR WRONG₄ THAT IMMUNITY GROWING TUMOR EPITOPESECHANISM UNCONTROLLED POTENTIALLY !N IMPORTANT DISTINCTION BETWEEN RELATENCE OF ALARM GENERAL EXAMPLE ADJUVANTTHE THE HEAT SHOCK PROTEINS  ACTIVATING

ACTIVATION OFICHMMUNICATE

INFLICTED

CONTRASTORSPANIEDSTRONG

DANGER SIGNALS INTO UNWANTED ACTIVATION OF 4 DESTRUCTION ANTICIPATE WHEN IMMUNOGENIC NOT WILL

TEMPTING TO SPECULATE THATDUCED

THAT 4CIAL CASE DURING (OWEVER IN TUMOR BEARING DETRIMENTAL

IMMUNITY EFFECTIVE ANTI TUMOR

IMMUNOTHERAPY )NSMALL NUMBER OF DRAINING  ₄ OF_{HELPER 4 CELLS}

#$_{PLETUMOR CELL}

INOCULATION WHICH #$_{PRESENCE OF} POPULATION IN TUMOR BEARING LACK INDUCTION_THOUT #$ SPONTANEOUSLY TRANSFER RECEPTOR TRANSGENIC CELLS INCREASED     O R BEAR IN G M IC E           $AYS   O R BEAR IN G M IC E           $AYS &IG₄ CELL MICE_LANK

LEFTz E MICE HAD

DEVELOPED{ 

 &+$37(5 2ECENTLY_#$4 VIVO WAS SHOWN TO ,IKEWISE OVERCOME _EDIATED SUPPRESSION )N TRIGGERING WITH ,03 SUPPRESSION

THATHERTO THE

EFFECTSERI #$P' )N TS MPORTANT IMPROVEMENT PATIENTSHEHERAPEUTIC WAYS TO OVERCOME A TAKEN INTO TUMOR WITH COULD PROVE TO BYPASSING COULD BE SUCCESSFUL #P' SPECIFIC RESULTING SURVIVALCHANGE WHICH TUMOR FROM IMMUNITY CELL TUMOR BEARING NEEDOR SPECIFIC !#+./7,%$'%-%.43 7ER 2%&%2%.#%3  -ELIEF #A 3 IMMUNOTHERAPYMUNOL  

 &ANNGTONCIENCYTHE #$

4 CELL LINEAGE TO RESPONSE TO SYNGENEIC(# ANTIGENSMUNOL   9EE 2OCHE0 $ !DOPTIVE 4 CELL FOR THE TREATMENT IN VIVO TRANSFERRED  

 $UDLEY * # (WU 0

3HERRYUBICKI 2OBINSON -

2

&REEZER% -AVROUKAKIS 3 ! 7HITE

$ % AND 2OSENBERG AUTOIMMUNITY ANTITUMOR 3EP  0ARDOLLROLE OF #$ 4 CELL )MMUNOL   /SSENDORPNGA 3 CELL    4OESNGA -ENGEDE % ANDOR 4

CYTOTOXIC YMPHOCYTES NST MAJOR

HISTOCOMPATIBILITY %XP

 /SSENDORP & -ENGEDE -ELIEF OPTIMAL MAJOR TUMORSED   $ANIEL$EHNE + MUNE %NHANCEMENT *ED   4ERABE

7ATSONARBONE $ 0 0AUL 7

% OF TUMOR IMMUNOSURVEILLANCE BY 34!4  4ANAKA ( 4ANAKA $EPLETION THE DRAINING   /NIZUKA

&UJITAAMAOR REJECTION BY IN VIVO

ADMINISTRATION ALPHA   3UTMULLER 2 0 VAN ! 0 4OES ELIEF

3YNERGISM TOTOXIC LYMPHOCYTE ASSOCIATED

ANTIGENOCKADEETION OF #$ REGULATORY

 &'7&(//668335(66$17,78025&7/5(63216(6

 4OES

+AST

TUMOR GROWTH

INDUCTION 0ROC .ATL !CAD 

 VAN -IERLOOEREDEMA

DER 6OORT %ELIEF

* ANDULATION

THERAPYUMORS

SYSTEMIC CYTOTOXIC 4

!CAD

 3CHOENBERGER 3

/FFRINGA 2 ANDTOTOXIC

4 LYMPHOCYTES INTERACTIONS  #ARDELL "ENOIST CELLS IN DEFICIENT  3HIMIZU)NDUCTION OF TUMOR IMMUNITYLS

COMMON BASIS BETWEEN

AUTOIMMUNITYMUNOL 

 0ROBST "ROEK DENDRITIC TOLERANCE

 +EENEANREQUIRED

FOR %XP  *ANSSEN % - ,EMMENS % 5#$ 4 MEMORY 

 3RIVASTAVA 0 2OLES SHOCK

ADAPTIVE   3HI 9 %VANS * % IDENTIFICATION OF SYSTEM 3EP  -ELIEF LYMPHOCYTE COEXISTENCE OF CROSS PRIMING )MMUNOL 

 ,YMANIGGSAN

! PROMOTE THE VE LYMPHOCYTES   0ASARE BLOCKADE BYCE *AN   9ANG 9 (UANG #L

0ERSISTENT 4OLL LIKE RECEPTOR REVERSAL .AT

 .IIMIITZKE

*.ONDEPLETING ANTI #$ MONOCLONAL

ANTIBODY ABILITY DELIVERY ALLOGRAFTS ORAL   3AITOVITCH $ "USHELL ! 2 * .IIMI - 7ITZKE / )NDUCTION OF

NONDEPLETING ANTI #$ FIC